SEC Company Response from Transphorm, Inc. (CIK 0001715768) — Sep 27, 2022
Transphorm, Inc. (CIK 0001715768)
Date: Sept. 27, 2022 · CIK: 0001715768 · Accession: 0001715768-22-000039
AI Filing Summary & Sentiment
File numbers found in text: 333-267522
Letter
Document
September 27, 2022
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-3720
Attention: Gregory Herbers
Re: Transphorm, Inc.
Registration Statement on Form S-3
File No. 333-267522
Filed on September 20, 2022
Acceleration Request
Requested Date: September 29 2022
Requested Time: 4:30 p.m. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Transphorm, Inc. hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-267522) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as we or our counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Please direct any questions regarding this request to Erika Muhl of Wilson Sonsini Goodrich & Rosati, P.C. ((650) 849-3352; emuhl@wsgr.com).
Sincerely,
TRANSPHORM, INC.
Show Raw Text
CORRESP 1 filename1.htm Document September 27, 2022 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-3720 Attention: Gregory Herbers Re: Transphorm, Inc. Registration Statement on Form S-3 File No. 333-267522 Filed on September 20, 2022 Acceleration Request Requested Date: September 29 2022 Requested Time: 4:30 p.m. Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Transphorm, Inc. hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-267522) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as we or our counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Please direct any questions regarding this request to Erika Muhl of Wilson Sonsini Goodrich & Rosati, P.C. ((650) 849-3352; emuhl@wsgr.com). Sincerely, TRANSPHORM, INC. By: /s/ Cameron McAulay Cameron McAulay Chief Financial Officer